Hepatitis C in Israeli prisons: status report

Area of Science:

• Public Health
• Infectious Disease Epidemiology
• Health Policy

Background:

• Hepatitis C (HCV) poses a significant health challenge in correctional facilities worldwide.
• Israeli prison policy regarding HCV diagnosis and treatment has undergone changes since 2016.
• Advocacy by human rights and medical groups has influenced policy shifts.

Purpose of the Study:

• To analyze changes in Israeli policy for hepatitis C (HCV) management in prisons since 2016.
• To evaluate the effectiveness of new diagnostic and treatment protocols for HCV in inmates.
• To identify persistent challenges and systemic issues in prison healthcare delivery for HCV.

Main Methods:

• Policy analysis of Israeli prison healthcare regulations concerning HCV.
• Review of data on HCV screening, diagnosis, and treatment rates among inmates.
• Examination of the impact of advocacy group campaigns and legal actions.

Main Results:

• Official policy changes include planned inmate screening and increased antiviral drug provision.
• Despite policy shifts, significant numbers of inmates still lack access to HCV treatment due to delays.
• Underdiagnosis of HCV may occur due to the absence of comprehensive screening programs.
• The prison healthcare system's administration by the Israel Prison Service, not a medical body, creates conflicts and resource limitations.

Conclusions:

• While policy changes are encouraging, implementation gaps remain in HCV care for Israeli inmates.
• The administrative structure of prison healthcare hinders equitable access to treatment and adequate resources.
• Continued advocacy and reform are crucial to ensure inmates' right to health, addressing systemic issues beyond HCV.